SC 13G

Company

Biodexa Pharmaceuticals Plc

Filed

March 6, 2023

Accession Number

0001753926-23-000248

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →